The Latest Cardiac and Vascular News
Acquisition further extends Rocket’s leadership in AAV-based cardiac gene therapy and expands focus and capabilities to BAG3-associated dilated cardiomyopathy CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces that […]
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins its Board of Directors as a permanent guest. Dr. Vardeny is an Associate professor of Medicine at the University of Minnesota Medical School, with […]
CHICAGO, Dec. 1, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) has announced the results of the 2022 member election for the 2023 Board of Directors as well as leadership positions in the Professional Communities. The Society will welcome six members to the Board of Directors […]
BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced the appointment of Michael E. Mendelsohn, MD to its Strategic Advisory Board. Dr. Mendelsohn is an internationally recognized cardiovascular physician-scientist, industry research leader and biopharma executive with four decades of broad healthcare and medical experience. Dr. Mendelsohn is […]
– Conference Call and Webcast Today, November 28, 2022 at 4:30 p.m. ET November 28, 2022 04:00 PM Eastern Standard Time PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal year ended September 30, 2022. The company is hosting a conference call today, November 28, […]
PARIS–(BUSINESS WIRE)–T-Heart, a medtech company developing a truly novel and differentiated transcatheter tricuspid prosthetic heart valve specifically designed for tricuspid regurgitation, today announced it has appointed Sarah Sorrel as its first independent member of the Board of Directors. Sarah Sorrel has more than 30 years’ experience in medical device regulation […]
WEST CHESTER, Pa., Nov. 28, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce that, Dr. Sean Lyden has agreed to assume the role of Chief Medical Consultant and also join the VESTECK Scientific Advisory Board. Dr. Lyden is currently the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold […]
Leading experts to help shape the future of Viz.ai’s radiology strategy and platform SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support radiologists and patients. […]
The Value Partnership includes a capital commitment by Atrium Health to purchase Siemens Healthineers equipment of more than $140M Siemens Healthineers and Atrium Health will focus on workforce development and improving access to care in rural and underserved areas CHARLOTTE, N.C. & MALVERN, Pa.–(BUSINESS WIRE)–Siemens Healthineers and Atrium Health, a […]
Financing co-led by Vensana Capital and a Large, Global Medical Device Company Use of Proceeds to Advance Development of a Novel Catheter-based Solution for Mitral Regurgitation ATLANTA, Nov. 23, 2022 /PRNewswire/ — Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, today announced the […]
